University of Bonn

Researchers

• HFHolger Fröhlich

Running trials

• Not yet recruiting

  Longitudinal Effects of Brain Stimulation on Decision-Making and Reward Learning

  NCT07823218· University of Bonn· Source

• Not yet recruiting

  An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function

  NCT07613398· Matthias Stuber· Source

• Not yet recruiting

  Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues

  NCT07074782· Association for Innovation and Biomedical Research on Light and Image· Source

• Recruiting

  tVNS, Motivation, and Insulin Sensitivity

  NCT07198100· University of Bonn· Source

• Recruiting

  Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)

  NCT06924021· University of Wisconsin, Madison· Source

• Recruiting

  Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC

  NCT06810609· Phase 2· University Hospital, Bonn· Source

• Enrolling by invitation

  tVNS and Obesity-related Mechanisms

  NCT06954844· University of Bonn· Source

• Recruiting

  PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

  NCT06102057· Phase 2· TheraOp· Source

• Enrolling by invitation

  Non-invasive Vagus Nerve Stimulation as a Tool to Modulate Stomach-Brain Coupling in Depression

  NCT06389175· University of Bonn· Source

• Recruiting

  Cohort Study on Plant-based Diets (COPLANT Study)

  NCT06323538· German Federal Institute for Risk Assessment· Source

• Recruiting

  Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients

  NCT06279793· Phase 2· GCP-Service International West GmbH· Source

• Active, not recruiting

  Clinical and translational controlled study of Perampanel treatment around Surgery in patients with progressive glioblastoma (PerSurge)

  2023-503938-52-00· Phase 2· Universitaetsklinikum Heidelberg AöR· Source

• Enrolling by invitation

  An Open-label Study of XEN1101 in Epilepsy

  NCT05718817· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).

  NCT05116189· Phase 3· Merck Sharp & Dohme LLC· Source

• Recruiting

  BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours

  NCT04421820· Phase 1/2· Bold Therapeutics, Inc.· Source

• Active, not recruiting

  Comparison of Carboplatin and Cisplatin in patients with extracranial malignant germ cell tumours

  2023-507582-25-00· Phase 3· Rheinische Friedrich-Wilhelms-Universitaet Bonn· Source

• Active, not recruiting

  Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

  NCT03007147· Phase 3· Children's Oncology Group· Source

• Recruiting

  Sporadic Degenerative Ataxia With Adult Onset: Natural History Study

  NCT02701036· Ataxia Study Group· Source

• Recruiting

  Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

  NCT00825929· Radboud University Medical Center· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression3 recruiting
• Lung cancer2 recruiting
• Obesity2 recruiting
• Atrial fibrillation1 recruiting
• Colorectal cancer1 recruiting
• Congenital heart disease1 recruiting
• Epilepsy1 recruiting
• Gastric and oesophageal cancer1 recruiting
• Glaucoma1 recruiting
• HIV1 recruiting
• Liver and biliary tract cancer1 recruiting
• Macular degeneration1 recruiting
• Multiple system atrophy1 recruiting
• Pancreatic cancer1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

  NCT05698316· Association for Innovation and Biomedical Research on Light and Image· Source

• Completed

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures

  NCT05614063· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Completed

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· Phase 3· Apellis Pharmaceuticals, Inc.· Source

• Completed

  Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1)

  NCT03364153· Phase 2· Astellas Pharma Global Development, Inc.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Alzheimer disease92 works · 0 trials
• Epilepsy47 works · 2 trials
• Macular degeneration42 works · 3 trials
• Glioblastoma32 works · 1 trial
• Schizophrenia30 works · 0 trials
• Haemophilia28 works · 0 trials
• Bipolar disorder18 works · 0 trials
• Glaucoma17 works · 1 trial
• Frontotemporal dementia9 works · 0 trials
• Lewy body dementia9 works · 0 trials
• Polycystic kidney disease5 works · 0 trials
• Spinal muscular atrophy4 works · 0 trials
• Alopecia areata4 works · 0 trials